Please log in to view this page
Username
Password
PK, safety and acceptability data and practical guidance on the optimal dosing of new more child-friendly formulations of...
The investigators are looking for a better way to prevent cervical cancer. This study is comparing two different methods to...
A5314 is a phase II randomized, double-blind, placebo-controlled 36-week trial that will examine the safety and efficacy of...
A5225/HiFLAC is a Phase I/II dose escalation and validation study of the safety, tolerability, and therapeutic effect of an...
Purpose: The C-TRIUMPH study has identified 20 household contacts (HHC), who have progressed to active TB from its HHCs cohort...
